We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News   Oct 16, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
Study Finds Commercially Available Antibodies Are Not Binding Their Target

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly. Credit: The Neuro.

 
 
Advertisement
 

RELATED ARTICLES

Study Investigates Potential Impact of Variant on COVID-19 Vaccine

News

Scientists are investigating whether neutralizing antibodies generated by current COVID-19 vaccines are able to recognize the B.1.1.7 SARS-CoV-2 variant. A new preprint shared by BioNTech and Pfizer outlines one such body of work.

READ MORE

How To Find Mutated Sperm? Just Go FISH

News

A new test quickly and easily identifies when sperm are carrying chromosomal mutations, and could be applied for men hoping to have children after chemotherapy and radiation treatments.

READ MORE

Volcano Home to Hundreds of Novel Microbes

News

Almost 300 novel types of microbes have been found living near a deep sea volcano. These microbes, which could be used in biotechnology and reveal new insights about their extreme underwater environment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE